Respiratory

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve…

Higher nighttime temperatures are linked to shorter sleep times and lower sleep quality, especially for people with chronic…

Researchers uncover a microbial signature in the lungs of severe pneumonia patients. Could this help explain survival differences…

Researchers have unveiled new AI tools, from smartphone cough analysis to child-friendly screening systems, which could transform how…

Amid concerns about the simultaneous spread of multiple respiratory diseases, such as colds and influenza, with the change…

Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus,…

How to organize your medicine cabinet Store your medicine in a cool, dry and dark place. Problem Solved…

A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV)…

Asthma is one of the most common chronic respiratory diseases among children, affecting nearly 475 million globally. For…

Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS…

New research from Mass General Brigham reveals that COVID-19 infection in pregnancy may subtly alter fetal brain development,…

Low oxygen levels in the blood can alter the genetic makeup of key immune cells, weakening the body’s…

Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis